PortfoliosLab logo

Bicycle Therapeutics plc (BCYC)

Equity · Currency in USD · Last updated Nov 30, 2022

Company Info

ISINUS0887861088
CUSIP088786108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$27.61
Year Range$12.95 - $60.87
EMA (50)$25.44
EMA (200)$30.83
Average Volume$204.63K
Market Capitalization$819.73M

BCYCShare Price Chart


Loading data...

BCYCPerformance

The chart shows the growth of $10,000 invested in Bicycle Therapeutics plc in May 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $23,008 for a total return of roughly 130.08%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%JulyAugustSeptemberOctoberNovember
76.75%
-5.25%
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)

BCYCCompare to other instruments

Search for stocks, ETFs, and funds to compare with BCYC

BCYCReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M10.40%1.45%
6M73.32%-4.82%
YTD-54.64%-16.96%
1Y-49.43%-13.86%
5Y26.71%10.08%
10Y26.71%10.08%

BCYCMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-19.78%-2.72%-7.62%-46.49%-31.90%4.94%40.41%12.27%-12.06%6.41%11.56%
202149.36%-5.74%18.20%3.78%-4.84%2.92%4.08%12.97%16.50%23.59%4.57%13.25%
202015.38%18.84%5.57%-6.23%39.61%-11.92%0.38%13.73%6.01%-2.83%15.40%-15.96%
2019-2.58%-13.94%-17.88%-11.15%55.18%-15.19%-9.32%7.65%

BCYCSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bicycle Therapeutics plc Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.62
-0.63
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)

BCYCDividend History


Bicycle Therapeutics plc doesn't pay dividends

BCYCDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-54.84%
-17.49%
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)

BCYCWorst Drawdowns

The table below shows the maximum drawdowns of the Bicycle Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bicycle Therapeutics plc is 78.82%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.82%Nov 16, 2021147Jun 16, 2022
-53.96%Jun 20, 201949Aug 28, 2019117Feb 14, 2020166
-41.61%Mar 11, 20209Mar 23, 202046May 28, 202055
-25.95%Feb 8, 202118Mar 4, 202120Apr 1, 202138
-20.84%Jul 26, 202119Aug 19, 20217Aug 30, 202126
-18.83%Feb 27, 20202Feb 28, 20203Mar 4, 20205
-18.7%Jul 16, 202041Sep 11, 20203Sep 16, 202044
-16.36%Apr 9, 20212Apr 12, 202164Jul 13, 202166
-15.98%Jun 9, 202017Jul 1, 20208Jul 14, 202025
-15.96%Dec 1, 202022Dec 31, 20209Jan 14, 202131

BCYCVolatility Chart

Current Bicycle Therapeutics plc volatility is 66.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%JulyAugustSeptemberOctoberNovember
66.83%
13.39%
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)